高危癌症患者群体中导管相关血流感染的危险因素
Risk factors for catheter-related bloodstream infections in a high-risk cancer patient population.
作者信息
Haddad Andrea, Wilson Dib Rita, Chaftari Anne-Marie, Jiang Ying, Moussa Mohamed, Dagher Hiba, Philip Ann, Hachem Ray, Raad Issam
机构信息
Department of Infectious Diseases, Infection Control and Employee Health, Unit 1460, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
出版信息
Infect Control Hosp Epidemiol. 2025 May 26;46(7):1-4. doi: 10.1017/ice.2025.45.
Abstract
To identify risk factors for catheter-related bloodstream infections (CRBSI) in cancer patients, we compared 200 CRBSI cases to 400 controls. Neutropenia, transplants, multiple catheters, blood products, and basilic/cephalic PICCs increased CRBSI risk, while jugular insertion was protective. Catheter site selection can reduce risk. Other targeted strategies are warranted.
摘要
为了确定癌症患者导管相关血流感染（CRBSI）的危险因素，我们将200例CRBSI病例与400例对照进行了比较。中性粒细胞减少、移植、多根导管、血液制品以及贵要静脉/头静脉经外周静脉穿刺中心静脉置管（PICC）会增加CRBSI风险，而颈内静脉置管具有保护作用。导管置管部位的选择可降低风险。还需要其他针对性策略。
相似文献
1
Risk factors for catheter-related bloodstream infections in a high-risk cancer patient population.高危癌症患者群体中导管相关血流感染的危险因素
Infect Control Hosp Epidemiol. 2025 May 26;46(7):1-4. doi: 10.1017/ice.2025.45.
2
The risk of catheter-related bloodstream infection with femoral venous catheters as compared to subclavian and internal jugular venous catheters: a systematic review of the literature and meta-analysis.股静脉置管与锁骨下静脉和颈内静脉置管相比与导管相关血流感染的风险：文献系统评价和荟萃分析。
Crit Care Med. 2012 Aug;40(8):2479-85. doi: 10.1097/CCM.0b013e318255d9bc.
3
The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.抗感染药物处理的中心静脉导管预防血流感染的临床有效性和成本效益：系统评价与经济学评估
Health Technol Assess. 2008 Apr;12(12):iii-iv, xi-xii, 1-154. doi: 10.3310/hta12120.
4
Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.用于降低成人中心静脉导管相关感染的导管浸渍、涂层或粘结
Cochrane Database Syst Rev. 2016 Mar 16;3(3):CD007878. doi: 10.1002/14651858.CD007878.pub3.
5
Frequency of dressing changes for central venous access devices on catheter-related infections.中心静脉通路装置换药频率与导管相关感染的关系
Cochrane Database Syst Rev. 2016 Feb 1;2(2):CD009213. doi: 10.1002/14651858.CD009213.pub2.
6
Interventions for treating catheter-related bloodstream infections in people receiving maintenance haemodialysis.治疗维持性血液透析患者导管相关血流感染的干预措施。
Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD013554. doi: 10.1002/14651858.CD013554.pub2.
7
Antimicrobial dressings for the prevention of catheter-related infections in newborn infants with central venous catheters.用于预防新生儿中心静脉导管相关感染的抗菌敷料。
Cochrane Database Syst Rev. 2016 Mar 23;3(3):CD011082. doi: 10.1002/14651858.CD011082.pub2.
8
Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.用于降低成人中心静脉导管相关感染的导管浸渍、涂层或粘结
Cochrane Database Syst Rev. 2013 Jun 6(6):CD007878. doi: 10.1002/14651858.CD007878.pub2.
9
Central venous access sites for the prevention of venous thrombosis, stenosis and infection.用于预防静脉血栓形成、狭窄和感染的中心静脉置管部位。
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD004084. doi: 10.1002/14651858.CD004084.pub3.
10
Clinically-indicated replacement versus routine replacement of peripheral venous catheters.外周静脉导管的临床指征性更换与常规更换
Cochrane Database Syst Rev. 2015 Aug 14(8):CD007798. doi: 10.1002/14651858.CD007798.pub4.
本文引用的文献
1
Risk factors of central catheter bloodstream infections in intensive care units: A systematic review and meta-analysis.重症监护病房中心静脉导管血流感染的危险因素：一项系统评价和荟萃分析。
PLoS One. 2024 Apr 23;19(4):e0296723. doi: 10.1371/journal.pone.0296723. eCollection 2024.
2
Obesity and risk of catheter-related infections in the ICU. A post hoc analysis of four large randomized controlled trials.肥胖与 ICU 患者导管相关感染的风险。四项大型随机对照试验的事后分析。
Intensive Care Med. 2021 Apr;47(4):435-443. doi: 10.1007/s00134-020-06336-4. Epub 2021 Feb 1.
3
The microbial biofilm composition on peripherally inserted central catheters: A comparison of polyurethane and hydrophobic catheters collected from paediatric patients.外周置入中心静脉导管上微生物生物膜的组成：从儿科患者收集的聚亚安酯和疏水性导管的比较。
J Vasc Access. 2021 May;22(3):388-393. doi: 10.1177/1129729820932423. Epub 2020 Jun 22.
4
Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients.血液系统恶性肿瘤和实体瘤患者中心静脉相关血流感染的发生率、危险因素和医疗保健成本。
PLoS One. 2020 Jan 24;15(1):e0227772. doi: 10.1371/journal.pone.0227772. eCollection 2020.
5
A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients.一种新型非抗生素类基于硝酸甘油的导管封管溶液，用于预防癌症患者管腔内中心静脉导管感染
Antimicrob Agents Chemother. 2017 Jun 27;61(7). doi: 10.1128/AAC.00091-17. Print 2017 Jul.
6
Prevention of biofilm colonization by Gram-negative bacteria on minocycline-rifampin-impregnated catheters sequentially coated with chlorhexidine.米诺环素-利福平浸渍导管序贯包被氯己定预防革兰氏阴性菌生物膜定植。
Antimicrob Agents Chemother. 2014;58(2):1179-82. doi: 10.1128/AAC.01959-13. Epub 2013 Oct 28.
7
Risk factors for upper extremity venous thrombosis associated with peripherally inserted central venous catheters.与外周静脉穿刺中心静脉导管相关的上肢静脉血栓形成的危险因素。
J Vasc Access. 2012 Apr-Jun;13(2):231-8. doi: 10.5301/jva.5000039.
8
Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.血管内导管相关感染的诊断与管理临床实践指南：美国感染病学会2009年更新版
Clin Infect Dis. 2009 Jul 1;49(1):1-45. doi: 10.1086/599376.
9
Recurrent catheter-related bloodstream infections: Risk factors and outcome.
Int J Infect Dis. 2006 Sep;10(5):396-400. doi: 10.1016/j.ijid.2005.08.002. Epub 2006 May 15.
10
The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters.非套囊短期中心静脉导管相关血流感染的发病机制
Intensive Care Med. 2004 Jan;30(1):62-7. doi: 10.1007/s00134-003-2045-z. Epub 2003 Nov 26.
Zotero 插件